Navigating Product Development and Compliance

Helping to navigate product development and compliance for the life science industry. Our SaaS-based solutions enable customers to structure their data and automate compliance processes with built-in quality templates and automated generation of deliverables to save time and money, delivering their products to market faster with less risk.

Blog Feature

Thought Leadership

How to Improve Your Design Controls Documentation

By: Cognition Corporation
October 24th, 2019

Generating and managing your compliance documentation for premarket submission takes a lot of time and effort. And when there are inconsistencies or other major issues, especially when it comes to design controls, a number of adverse effects could impact your organization. From time lost to remediation to delays to market, it can seriously cost your life science organization. To combat these issues, you can use a number of tactics to improve your design controls documentation.

Read More

Share

Blog Feature

Thought Leadership

4 Steps to Better Internal Auditing in Life Science Product Development

By: Cognition Corporation
October 22nd, 2019

Internal auditing is an important activity for life science organizations not just during product development, but through the overall product life cycle as well. It allows your business to self-monitor according to the necessary quality management system (QMS) rules and requirements laid out by FDA and other regulatory bodies. But some organizations might find themselves struggling with this compliance aspect: how do you ensure your internal auditing is up to standard? Here are four steps you can take to improve your auditing capabilities and efficacy.

Read More

Share

How to Approach Usability Engineering & Use Error Analysis

Learn how activities like Use Error Analysis can lead to more dynamic, impactful risk management.

Subscribe to the blog and get this guide for free

Blog Feature

Thought Leadership

3 Ways to Improve Your Premarket Submission Documentation

By: Cognition Corporation
October 17th, 2019

Submitting your life science product for premarket review is a stressful endeavor; if it is rejected by regulators for insufficient documentation or other issues, it can result in lost time to market and loss of time and resources in remediation. Overcoming those issues is not an easy thing, and knowing what to do is not readily apparent. However, there are three important strategies your organization can use to improve your premarket submission documentation, potentially reducing the likelihood of rejection.

Read More

Share

Blog Feature

Thought Leadership | Industry Updates

FDA Pulse Check: September 2019

By: Cognition Corporation
October 15th, 2019

FDA released a number of important updates in September 2019, spanning from their premarket submission pathways to integral policy updates. Here are a few of the important highlights from the month.

Read More

Share

Blog Feature

Thought Leadership

Best Practices for Implementing Compliance Software into an Organization

By: Cognition Corporation
October 9th, 2019

Congratulations! So, you’ve decided to adopt a compliance software tool for your life science organization. However, you’re only at the start of a big implementation process—one that has a lot of moving parts and work attached. How do you make the start of using compliance software the best process it can be?

Read More

Share

Blog Feature

Thought Leadership

"Fuzzy Front End": What is it?

By: Cognition Corporation
October 2nd, 2019

Have you heard the term “fuzzy front end” (FFE) before? What does that even mean?

Read More

Share

Blog Feature

Thought Leadership

Strategies for Promoting User Adoption of Compliance Software Tools

By: Cognition Corporation
September 26th, 2019

Implementing a new compliance software tool into your organization isn’t easy. Between establishing new processes, evaluating impacts on your quality system, and determining short- and long-term timelines of adoption and use, there are a lot of considerations to be managed. On top of that, getting your teams to use the tool is an entirely different challenge; if there’s resistance, then things only get more complicated. So how do you promote user adoption for new compliance software?

Read More

Share

Blog Feature

FDA | Thought Leadership

An Overview of the Latest 510(k) Submissions Final Guidance

By: Cognition Corporation
September 24th, 2019

September 2019 saw the release of several final guidance documents relating to 510(k) submissions. One of the most utilized pathways by medical device manufacturers, the 510(k) has evolved quite a bit over time. The release of all these new documents speaks to FDA’s commitment to keeping this method of premarket submission up-to-date and aligned with agency directives. Taking a brief, high-level overview of each of these final guidance documents is extremely important for organizations looking to stay ahead of the ever-changing regulatory landscape.

Read More

Share

Blog Feature

FDA | Thought Leadership

Determining if Your Medical Device is Appropriate for the Special 510(k) Program

By: Cognition Corporation
September 19th, 2019

In September 2019, FDA released final guidance on its Special 510(k) Program. This optional pathway allows medical device manufacturers a simplified approach to submitting changes to their legally marketed products, provided they are currently well-understood by the agency. However, figuring out whether or not your submission qualifies under the Special 510(k) is tricky. Diving into the final guidance, there are hallmarks you can use to understand your device’s qualification under this program.

Read More

Share